Evidence map›Paper›PMID 24372197›Full record

ArticleAnalytical chemistry2014

Enhancing the detection limit of nanoscale biosensors via topographically selective functionalization.

Mark A Lifson, Dhrubajyoti Basu Roy, Benjamin L Miller

Abstract read
In one paragraph

Article in Analytical chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Optical Detection of FeSensors (Basel, Switzerland) · 2019
    Article
  3. Selective Functionalization with PNA of Silicon Nanowires on Silicon Oxide Substrates.Langmuir : the ACS journal of surfaces and colloids · 2018
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mark A LifsonDepartment of Biomedical Engineering, ¶Department of Biochemistry and Biophysics and #Department of Dermatology, University of Rochester , Rochester, New York 14627, United States.
Dhrubajyoti Basu Roy
Benjamin L Miller

Funding

Training in HIV Replication and PathogenesisT32AI049815 · NIAID · UNIVERSITY OF ROCHESTER · PI WEDEKIND, JOSEPH E · 2001 to 2020
$3.5M
Photonic structures for direct ultrasensitive virus detectionR01AI080770 · NIAID · UNIVERSITY OF ROCHESTER · PI MILLER, BENJAMIN L · 2009 to 2012
$1.4M
NIAID NIH HHS R01 AI080770NIAID NIH HHS T32 AI049815NIAID NIH HHS T32AI049815-12PHS HHS R01A108077-01
6 · The paper itself

Abstract

Nanoscale biosensors have remarkable theoretical sensitivities but often suffer from suboptimal limits of detection in practice. This is in part because the sensing area of nanoscale sensors is orders of magnitude smaller than the total device substrate. Current strategies to immobilize probes (capture molecules) functionalize both sensing and nonsensing regions, leading to target depletion and diminished limits of detection. The difference in topography between these regions on nanoscale biosensors offers a way to selectively address only the sensing area. We developed a bottom-up, topographically selective approach employing self-assembled poly(N-isopropylacrylamide) (PNIPAM) hydrogel nanoparticles as a mask to preferentially bind target to only the active sensing region of a photonic crystal (PhC) biosensor. This led to over an order of magnitude improvement in the limit of detection for the device, in agreement with finite element simulations. Since the sensing elements in many nanoscale sensors are topographically distinct, this approach should be widely applicable.

Indexed as

Acrylic ResinsAntibodies, Anti-IdiotypicAntibodies, ImmobilizedBiosensing TechniquesFluorescent DyesHumansHydrogelsImmunoglobulin GLimit of DetectionNanoparticlesOptical PhenomenaRhodaminesSilicon CompoundsAcrylic ResinsAntibodies, Anti-IdiotypicAntibodies, Immobilizedanti-IgGFluorescent DyesHydrogelsImmunoglobulin Gpoly-N-isopropylacrylamideRhodaminesSilicon Compounds

Identifiers

PMID24372197
PMCPMC3923412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.